To evaluate the effects of citalopram, paroxetine and sertraline in adults with depression with suicidal ideation.

Trial Profile

To evaluate the effects of citalopram, paroxetine and sertraline in adults with depression with suicidal ideation.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2018

At a glance

  • Drugs Citalopram (Primary) ; Paroxetine (Primary) ; Sertraline (Primary)
  • Indications Depression; Suicidal ideation
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2018 New trial record
    • 05 Feb 2018 Results published in the British Journal of Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top